These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 287557)

  • 1. Clinical studies with rubidazone.
    Benjamin RS; Keating MJ; Swenerton KD; Legha S; McCredie KB
    Cancer Treat Rep; 1979 May; 63(5):925-9. PubMed ID: 287557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rubidazone in adults with previously treated acute leukemia and blast cell phase of chronic myelocytic leukemia: a Southwest Oncology Group Study.
    Bickers J; Benjamin R; Wilson H; Eyre H; Hewlett J; McCredie K
    Cancer Treat Rep; 1981; 65(5-6):427-30. PubMed ID: 6940659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase I and clinical pharmacological study of 4-demethoxydaunorubicin (idarubicin) in children with advanced cancer.
    Tan CT; Hancock C; Steinherz P; Bacha DM; Steinherz L; Luks E; Winick N; Meyers P; Mondora A; Dantis E
    Cancer Res; 1987 Jun; 47(11):2990-5. PubMed ID: 3471321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized phase II trial of rubidazone and adriamycin in women with advanced breast cancer.
    Ingle JN; Ahmann DL; O'Fallon JR; Bisel HF; Rubin J; Kvols LK; Giuliani ER
    Cancer Treat Rep; 1979; 63(11-12):1701-5. PubMed ID: 526908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Phase II trial of mitoxantrone in patients with relapsed and refractory acute leukemia].
    Sampi K; Ogawa M; Kimura I; Ohnoshi T; Yamada K; Masaoka T; Wakui A; Meguro S; Nagai K; Kitani T
    Gan To Kagaku Ryoho; 1986 Oct; 13(10):3021-7. PubMed ID: 3464230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase I--II evaluation of a new anthracycline antibiotic, aclacinomycin A, in adults with refractory leukemia.
    Warrell RP; Arlin ZA; Kempin SJ; Young CW
    Cancer Treat Rep; 1982 Aug; 66(8):1619-23. PubMed ID: 6955022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A pilot study of high-dose 1-beta-D-arabinofuranosylcytosine for acute leukemia and refractory lymphoma: clinical response and pharmacology.
    Early AP; Preisler HD; Slocum H; Rustum YM
    Cancer Res; 1982 Apr; 42(4):1587-94. PubMed ID: 6949642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase I clinical investigation of benzisoquinolinedione (amonafide) in adults with refractory or relapsed acute leukemia.
    O'Brien S; Benvenuto JA; Estey E; Beran M; Felder TB; Keating M
    Cancer Res; 1991 Feb; 51(3):935-8. PubMed ID: 1988134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase I and II clinical and pharmacological study of 4-demethoxydaunorubicin (idarubicin) in adult patients with acute leukemia.
    Daghestani AN; Arlin ZA; Leyland-Jones B; Gee TS; Kempin SJ; Mertelsmann R; Budman D; Schulman P; Baratz R; Williams L
    Cancer Res; 1985 Mar; 45(3):1408-12. PubMed ID: 3855696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase I clinical trial of orally administered 4-demethoxydaunorubicin (idarubicin) with pharmacokinetic and in vitro drug sensitivity testing in children with refractory leukemia.
    Pui CH; de Graaf SS; Dow LW; Rodman JH; Evans WE; Alpert BS; Murphy SB
    Cancer Res; 1988 Sep; 48(18):5348-52. PubMed ID: 3165708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase I study of aziridinylbenzoquinone (AZQ, NSC 182986) in children with cancer.
    Tan CT; Hancock CH; Mondora A; Hoffman NW
    Cancer Res; 1984 Feb; 44(2):831-5. PubMed ID: 6692381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A phase II study of epirubicin in acute leukemia: a cooperative group study].
    Sampi K; Masaoka T; Shibata H; Shirakawa S; Kobayashi T; Shirai T; Umeda M; Kozuru M; Sugiyama H; Oguro M
    Gan To Kagaku Ryoho; 1986 Aug; 13(8):2594-9. PubMed ID: 3461746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequentially administered 5-azacitidine and amsacrine in refractory adult acute leukemia: a phase I-II trial of the Southeastern Cancer Study Group.
    Winton EF; Hearn EB; Martelo O; Presant CA; Adler S; Vogler WR; Raney M; Logan T; Silberman HM; Omura GA
    Cancer Treat Rep; 1985; 69(7-8):807-11. PubMed ID: 2410119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Phase II trial of mitoxantrone in patients with relapsed and refractory acute leukemia].
    Sampi K; Kaneko Y; Maseki N; Kumai R; Sakurai M; Hattori M
    Gan To Kagaku Ryoho; 1985 Jul; 12(7):1453-7. PubMed ID: 4015120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tallimustine, an effective antileukemic agent in a severe combined immunodeficient mouse model of adult myelogenous leukemia, induces remissions in a phase I study.
    Beran M; Jeha S; O'Brien S; Estey E; Vitek L; Zurlo MG; Rios MB; Keating M; Kantarjian H
    Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2377-84. PubMed ID: 9815637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase II evaluation of teniposide and ifosfamide in refractory adult acute lymphocytic leukemia: a Southwest Oncology Group Study.
    Ryan DH; Kopecky KJ; Head D; Gumbart CN; Grever MR; Karanes C; Weick JK; Coltman CA
    Cancer Treat Rep; 1987; 71(7-8):713-6. PubMed ID: 3475171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral idarubicin as single-agent treatment of acute nonlymphocytic leukemia in poor-risk patients.
    Lowenthal RM; Chesterman CN; Griffiths JD; Manoharan A; Harris MG; Herrmann RP; Rooney KF; Rozenberg MC; Salem HH; Wolf MM
    Cancer Treat Rep; 1987 Dec; 71(12):1279-81. PubMed ID: 3480044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Limited activity of ICRF-159 in advanced acute leukemia.
    Bakowski MT; Prentice HG; Lister TA; Malpas JS; McElwain TJ; Powles RL
    Cancer Treat Rep; 1979 Jan; 63(1):127-9. PubMed ID: 369684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aclarubicin in the treatment of acute nonlymphocytic leukemia refractory to treatment with daunorubicin and cytarabine: a phase II trial.
    Pedersen-Bjergaard J; Brincker H; Ellegaard J; Drivsholm A; Freund L; Jensen KB; Jensen MK; Nissen NI
    Cancer Treat Rep; 1984 Oct; 68(10):1233-8. PubMed ID: 6597002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase I-II study of piperazinedione in adults with solid tumors and acute leukemia.
    Benjamin RS; Keating MJ; Valdivieso M; McCredie KB; Livingston RA; Burgess MA; Rodriguez V; Bodey GP; Gottlieb JA
    Cancer Treat Rep; 1979 Jun; 63(6):939-43. PubMed ID: 380802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.